Ghana

The Global Fund to Fight AIDS, Tuberculosis and Malaria selects PATH to lead the Sustainable and Integrated Data Systems grant to support integration efforts in Zambia, Senegal, and Ghana.

On April 15, 2026, PATH held a webinar on opportunities for collaboration between country malaria and immunization programs on malaria vaccine implementation. Speakers from Ghana and Nigeria shared real-world examples, highlighting what’s worked and lessons learned so far.The session was moderated by Rose Zulliger, Director of Technical Services and Innovation, Malaria Consortium, with a welcome by John Bawa, Global Technical Director – Malaria Vaccines, PATH. Featured speakers included Dr. Nnenna Ogbulafor, National Coordinator of National Malaria Elimination Program, Nigeria, and Dr. Naziru Tanko Mohammed, Deputy EPI Manager, Ghana.This was the second instance in a quarterly webinar series this year on learnings from malaria vaccine rollout in Africa. Explore resources from all of PATH's malaria vaccine webinars here.

This endline brief summarizes a two-year collaboration between PATH, the Ghana Health Service, and partners to strengthen health and nutrition services for children under five in early childhood development centers across Ghana. Through a co-created, government-aligned approach piloted in 24 schools, the project improved implementation of school health and nutrition policies, expanded the use of child health records and routine health checks, and introduced engaging, play-based learning tools to build children’s knowledge of nutrition.

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory tract infections in young children. Two preventive interventions for RSV—a maternal vaccine and long-acting monoclonal antibodies (mAbs) delivered to infants—are recommended by the World Health Organization. When countries consider introducing new vaccines, immunization program cost and affordability are key questions.To address some of these questions, the University Medical Centre Utrecht and PATH conducted studies as part of a multi-country collaboration called the RSV GOLD III-Health Economics Study to evaluate the economic burden of RSV disease (or cost of illness) and the impact and cost-effectiveness of RSV prevention (e.g., via maternal immunization or long-acting monoclonal antibodies) in Gavi, the Vaccine Alliance-eligible countries. The estimates will help inform policy decisions in low- and middle-income countries where maternal immunization-preventable diseases often hit hardest.Find here links to the peer-reviewed journal articles and select fact sheets summarizing the research. [Note: Some publications and fact sheets are forthcoming.]

A bold scientific effort to reimagine rotavirus vaccination is leaving a lasting legacy—and opening new doors for innovation.

When countries consider introducing new vaccines, immunization program cost and affordability are key questions. Data are limited on what vaccinating pregnant populations costs. To help fill this gap, PATH conducted prospective studies in collaboration with ministries of health and other partners to understand cost of delivery and introduction implications for new vaccines given in pregnancy in Bangladesh, Ghana, Kenya, Mozambique, and Nepal. The estimates will help inform policy decisions in low- and middle-income countries where maternal immunization-preventable diseases often hit hardest.Find here links to the peer-reviewed journal articles and fact sheets summarizing the research from all countries. (Materials available in English and, as applicable, in Portuguese.)

Building on lessons from the last six years, PATH is supporting countries as they roll out this lifesaving intervention.

This report shares the results of a value proposition study that PATH conducted to better understand stakeholder perspectives in four countries on potential use cases and target populations for a human hookworm vaccine and to explore the idea of a hookworm/malaria combination vaccine. The Democratic Republic of Congo, Ghana, Malawi, and Uganda were selected for the study because they all have demonstrated hookworm and malaria disease burdens. Providing protection against both diseases with a single vaccine could offer an efficient, effective, and affordable way to improve health in low- and middle-income countries.

Poor water, sanitation, and hygiene practices contribute to the spread of infections and negative health outcomes in communities and health care settings. Globally, roughly 3.85 billion people use health facilities that lack basic hand hygiene services, while 1.7 billion people access health facilities that lack basic water services. Achieving the United Nations Sustainable Development Goal 6 (SDG 6)—ensuring access to water and sanitation for all—demands innovative and strategic solutions.One such solution is the Aqua Research STREAM™ Disinfectant Generator (STREAM). The STREAM is an onsite chlorine generator that uses common salt and water to generate liquid chlorine that meets global standards for intermediate–level disinfection of surfaces in health care settings and can be used for treating drinking water.With funding from the Conrad N. Hilton Foundation and in collaboration with ministries of health, this learning brief series provides real–world examples and lessons learned from implementing the STREAM in three countries: Ghana, Uganda, and Ethiopia.It describes how PATH, in collaboration with ministries of health, is using the SDG 6 Global Accelerator Framework to introduce and scale up the STREAM on a national level.

In January 2024, PATH and Ghana Health Services (GHS), with support from the Bainum Family Foundation, entered into a partnership to develop and test strategies to support early childhood development centers in providing better health and nutrition services. This brief details the background, activities, initial results, and next steps.